Additionally, STING can reverse immunosuppressive conditions by reprogramming myeloid-derived suppressor cells into antigen-presenting cells [8,9] and polarizing tumor-promoting M2 macrophages toward the anti-tumor M1 phenotype [10]. The gene discussed is STING1; the disease is neoplasm.